We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.22B
AUM Growth
-$44.8M
Cap. Flow
+$3.01M
Cap. Flow %
0.25%
Top 10 Hldgs %
29.85%
Holding
194
New
3
Increased
55
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$950K
2
CB icon
Chubb
CB
+$761K
3
BLKB icon
Blackbaud
BLKB
+$689K
4
HXL icon
Hexcel
HXL
+$638K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$628K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$1.84M
2
FDX icon
FedEx
FDX
+$1.8M
3
MSFT icon
Microsoft
MSFT
+$1.69M
4
SNPS icon
Synopsys
SNPS
+$1.41M
5
AAPL icon
Apple
AAPL
+$727K

Sector Composition

Rank Sector Weight
1 Technology 27.18%
2 Healthcare 16.06%
3 Industrials 11.8%
4 Financials 11.68%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
76
Alphabet (Google) Class A
GOOGL
$4.12T
$1.95M 0.16%
20,360
-100
-0.5% -$11.1K
TJX icon
77
TJX Companies
TJX
$179B
$1.81M 0.15%
29,187
SPY icon
78
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$1.6M 0.13%
4,480
ADP icon
79
Automatic Data Processing
ADP
$109B
$1.56M 0.13%
6,881
CL icon
80
Colgate-Palmolive
CL
$74.8B
$1.52M 0.12%
21,616
-825
-4% -$64.7K
NBIX icon
81
Neurocrine Biosciences
NBIX
$18.2B
$1.52M 0.12%
14,279
+352
+3% +$35.7K
HD icon
82
Home Depot
HD
$337B
$1.5M 0.12%
5,424
HON icon
83
Honeywell
HON
$76.4B
$1.43M 0.12%
9,100
-106
-1% -$18.5K
ABT icon
84
Abbott
ABT
$188B
$1.38M 0.11%
14,278
BMY icon
85
Bristol-Myers Squibb
BMY
$129B
$1.35M 0.11%
19,012
+903
+5% +$65.5K
AMZN icon
86
Amazon
AMZN
$2.44T
$1.31M 0.11%
11,611
-110
-0.9% -$13.9K
CTRA
87
DELISTED
Coterra Energy
CTRA
$1.31M 0.11%
50,104
FAST icon
88
Fastenal
FAST
$54.8B
$1.31M 0.11%
56,892
IONS icon
89
Ionis Pharmaceuticals
IONS
$8.93B
$1.29M 0.11%
29,071
+795
+3% +$33.5K
MMM icon
90
3M
MMM
$91.8B
$1.28M 0.1%
13,902
+457
+3% +$50.1K
BMRN icon
91
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.22M 0.1%
14,373
+372
+3% +$33.1K
IVV icon
92
iShares Core S&P 500 ETF
IVV
$858B
$1.07M 0.09%
2,972
INCY icon
93
Incyte
INCY
$25.4B
$1.06M 0.09%
15,915
+350
+2% +$25.9K
UNP icon
94
Union Pacific
UNP
$174B
$1.02M 0.08%
5,257
VV icon
95
Vanguard Large-Cap ETF
VV
$51.2B
$1.02M 0.08%
6,208
EMR icon
96
Emerson Electric
EMR
$81.6B
$960K 0.08%
13,064
EBAY icon
97
eBay
EBAY
$51.2B
$940K 0.08%
25,489
-1,520
-6% -$67.7K
LLY icon
98
Eli Lilly
LLY
$1.08T
$940K 0.08%
2,921
IWB icon
99
iShares Russell 1000 ETF
IWB
$47.1B
$900K 0.07%
4,564
MCD icon
100
McDonald's
MCD
$193B
$880K 0.07%
3,825
-8
-0.2% -$2.04K

Similar funds

Grandfield & Dodd's Q3 2022 Portfolio in Review

As of Q3 2022, Grandfield & Dodd held 194 positions worth $1.22B, down 3.5% from $1.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q3 2022 filing shows 3 new, 55 increased, 48 reduced and 9 closed positions. Its largest new stake was Genmab: 10,210 shares worth $330K. The largest sale was Brunswick, an estimated $1.84M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2022 buy was Genmab: 10,210 shares worth $330K.
  • Grandfield & Dodd added most to People Inc in Q3 2022, an estimated $950K increase.
  • Grandfield & Dodd's biggest Q3 2022 reduction was Brunswick, cutting an estimated $1.84M.
  • Grandfield & Dodd fully exited Verizon in Q3 2022, selling an estimated $420K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.22B portfolio in Q3 2022.
  • Grandfield & Dodd opened 3 new positions and closed 9 in Q3 2022.
  • Grandfield & Dodd's portfolio value fell 3.5% quarter-over-quarter to $1.22B.

Based on Grandfield & Dodd's 13F filing for Q3 2022, filed 4 Nov 2022.